Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Return to the main site

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Device Daily Bulletin > HeartSine to Correct Samaritan Defibrillators Following Five Deaths

FDAnews Device Daily Bulletin

Oct. 29, 2012 | Vol. 9 No. 212

HeartSine to Correct Samaritan Defibrillators Following Five Deaths

HeartSine Technologies, a medical device manufacturer based in the UK, announced that it would launch a global correction for its Samaritan 330/300P public access defibrillators.
Qmed

Register Now
Print This Page
Email This Article
RSS
Archives

Related Articles

German Police Seize Nearly 200 Stents From Boston Scientific Corporation ALung Pursues Chinese Approval for Hemolung CRMC Patients May Have Received Insulin Pen Injection With Used Device Get Happy About Depression Study Results

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.